Tag Archives: cancer

We Are the Worldview

Worldview

Now in its 6th consecutive year, Scientific American Worldview: A Global Biotechnology Perspective will have its official launch in a special Super Session at the BIO International Convention today at 2pm. Moderated by television and radio personality David Brancaccio (Marketplace Morning; PBS Now) this exciting event will explore the ever-globalized ethos of life science innovation and examine the many multicultural elements driving new partnerships, new products and new paradigms. Scientific American Worldview is a collaborative Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

Integrate and Collaborate to Drive Advancements in Oncology Treatments

A New Paradigm in Oncology Treatment

Scientific innovation and exploration have driven exciting changes in the pharmaceutical industry’s understanding of cancer, from improvements in screening to the development of more personalized, treatments. In a 2014 BIO International Convention Super Session on Tuesday moderated by BioCentury Editor Susan Schaeffer, panelists discussed the pressing need for companies to increase collaboration with each other and with industry stakeholders, including patient advocacy groups and academic medical centers, to speed the development and delivery of new Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Forbes: Sure, We’ll (Eventually) Beat Cancer. But Can We Afford To?

Biopharmaceuticals and Accountable Care Organizations: Balancing Cost and Quality

On May 19, Paul Howard highlighted the promise of immunotherapy for the treatment and possible eventual cure of cancer but emphasized that it is critical to focus on the long-term perspective. Key points raised in the article: ‘Reducing incentives for innovation (and drug development returns are roughly comparable to those in the software industry) and you would encourage investors to park more of their capital in more lucrative investments (think: Snapchat), and less into research for Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Immuno Oncology – A 30-year Overnight Success Story

Photo Feb 11, 1 30 16 PM

“It was the Rodney Dangerfield space – couldn’t get no respect” One would never guess those words were used to describe immuno-oncology, a field that has recently bloomed into full-fledged frenzy – with private companies raising unprecedented Series As, impressive data being announced and Science designating the field “Breakthrough of the Year” all in 2013. Yet Dr. Jeffrey Weber, an early member in the “i-onc” research community likened the past several decades of immuno-oncology to Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

2013 Novel Drug Approvals

Therapeutic-Indications-with-Novel-Drug-Approvals-in-2013-115x76

The FDA approved 24 novel drugs last year by our count, in line with average approvals for the last ten years but down from the decade-high approvals seen in 2012. Our count is a bit lower than the FDA’s count of 27 new approvals, because we did not include imaging agents like Navidea’s Lymphoseek, or reformulations like J&J’s Simponi Aria. 2013 was the first year the breakthrough-designated therapies were approved, with three breakthrough therapies approved: Gilead’s Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,